Douglas Lane & Associates’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-18,150
Closed -$606K 210
2017
Q3
$606K Sell
18,150
-341,231
-95% -$11.8M 0.01% 166
2017
Q2
$12.8M Sell
359,381
-899,147
-71% -$30.4M 0.3% 88
2017
Q1
$38.7M Buy
+1,258,528
New +$38.8M 0.96% 42

Other funds holding QGEN

Douglas Lane & Associates's QGEN Position: Q4 2017 in Review

Douglas Lane & Associates sold out of Qiagen (QGEN) in Q4 2017, closing a stake of 18,150 shares — an estimated $606K sold.

Douglas Lane & Associates first reported a position in QGEN in Q1 2017 and held it in 3 quarters. The position peaked at $38.7M in Q1 2017. 215 funds tracked by Wall St. Rank hold QGEN as of Q4 2017.

  • Douglas Lane & Associates reported no remaining Qiagen position as of Q4 2017 after selling out during the quarter.
  • Douglas Lane & Associates sold 18,150 Qiagen shares in Q4 2017, an estimated $606K.
  • Douglas Lane & Associates first reported a position in Qiagen in Q1 2017 and held it in 3 quarters.
  • Douglas Lane & Associates's Qiagen position peaked at $38.7M in Q1 2017.
  • 215 funds tracked by Wall St. Rank held Qiagen as of Q4 2017.

Based on Douglas Lane & Associates's 13F filing for Q4 2017, filed 24 Jan 2018.